THE STORY BEHIND THE WORLD VACCINE CONGRESS

The World Vaccine Congress is now well-established as the must attend global vaccine event each year, where leaders of the industry come to discuss science and do business.   Now in its 17th year, the event in 2017 will bring over 700 senior vaccine executives to learn, meet and form partnerships.

As always, the Congress will cover the crucial topics which are affecting the whole sector. From putting together a global strategy to respond to the next Zika virus , to exploring new vaccine technologies all from key KOLs from the WHO, FDA , big pharma and leading institutions .

Our agenda format also allows for whole-sector topics by running 8 parallel niche conferences over 2 days of the Congress, increasing the relevance of the whole event for everyone who attends.

 

Choose the sessions which are most applicable  to help your business plan for the future of vaccine research, development and manufacture

The impact of this was to increase the quality of the speaker line-up and those who signed up to attend, as the content truly moved forward, covering the important blue-sky keynotes whilst also providing personalised content for every attendee.

In 2017, we will be building on this success to bring the community together for debate and discussion that is not available elsewhere, because of the quality of sessions you can participate in and the attendees who will be on-site.

Make sure you don’t miss out on the one event which facilitates the future of the vaccine industry.

 

New vaccine technology is changing the whole industry

 

Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, we have content, networking and potential partners for you.

By bringing eight events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.

 

Take just three days out of the office to meet with 700+ potential customers who need to find solutions to their challenges.

 

INFLUENZA AND RESPIRATORY

Find ways to improve development of universal influenza, RSV, MERS and Pneumococcal vaccines

 

BIOPROCESSING AND MANUFACTURING

Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies

 

CANCER AND IMMUNOTHERAPY

From new adjuvant technologies to novel immunotherapies, better understand the latest developments in the fast-evolving cancer landscape

 

IMMUNE PROFILING

Discuss how profiling of the immune system using high throughput technologies can aid therapeutic design and treatment strategies in infectious and noninfectious diseases including cancer

 

 

World Vaccine Congress Washington 2017 -  our story map

PARTNERSHIPS

Hear from exciting new vaccine biotechs presenting on their pipeline as well as case studies and on how best to form public-private partnerships

 

EMERGING AND RE-EMERGING DISEASES

Understand the opportunities for your business in reacting to global threats like malaria, dengue and Ebola

 

CLINICAL TRIALS

Assess how to improve your clinical trial performance, from developing novel immunological assays to creating clinical efficacy

 

VETERINARY

From livestock to companion, gain crucial insights into the emerging infections and new technologies changing the landscape

 

 

 

Get involved

To exhibit, sponsor or speak at the event contact
Marc Rhys-Evans on +44 (0)20 7827 5945
or marc.rhys-evans@terrapinn.com